Financial insights of KMTS

MyFinsight

For the quarter ending 2026-01-31, KMTS made $24,552K in revenue. -$34,166K in net income. Net profit margin of -139.16%.

Income Statement	2026-01-31	2025-10-31	2025-07-31
Revenue	24,552	22,565	-
Cost of revenue	11,646	11,141	-
Gross profit	12,906	11,424	-
Research and development	4,972	4,878	-
Selling, general and administrative	42,699	38,301	-
Total operating expenses	47,671	43,179	-
Loss from operations	-34,765	-31,755	-
Interest expense	1,888	1,901	-
Interest income	2,163	1,796	-
Other expense (income)	359	-891	-
Net loss before provision for income taxes	-34,131	-32,751	-
Provision for income taxes	35	34	-
Net loss and comprehensive loss	-34,166	-32,785	-
Net loss and comprehensive loss attributable to kestra medical technologies, ltd	-34,166	-32,785	-25,826
Net loss attributable to common shareholders, diluted	-	-	-25,826
Net loss attributable to common shareholders, basic	-34,166	-32,785	-

Basic EPS	-0.61	-0.64	-0.5
Diluted EPS	-0.61	-0.64	-0.5
Basic Average Shares	55,848,413	51,376,278	51,304,599
Diluted Average Shares	55,848,413	51,376,278	51,304,599

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.